BRPI0908756A2 - Uso combinado de derivado do colestanol - Google Patents

Uso combinado de derivado do colestanol

Info

Publication number
BRPI0908756A2
BRPI0908756A2 BRPI0908756-7A BRPI0908756A BRPI0908756A2 BR PI0908756 A2 BRPI0908756 A2 BR PI0908756A2 BR PI0908756 A BRPI0908756 A BR PI0908756A BR PI0908756 A2 BRPI0908756 A2 BR PI0908756A2
Authority
BR
Brazil
Prior art keywords
combined use
cholestanol derivative
cholestanol
derivative
combined
Prior art date
Application number
BRPI0908756-7A
Other languages
English (en)
Inventor
Shin Yazawa
Toyo Nishimura
Takayuki Asao
Original Assignee
Otsuka Pharma Co Ltd
Univ Gunma Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ Gunma Nat Univ Corp filed Critical Otsuka Pharma Co Ltd
Publication of BRPI0908756A2 publication Critical patent/BRPI0908756A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0908756-7A 2008-03-05 2009-03-04 Uso combinado de derivado do colestanol BRPI0908756A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008055284 2008-03-05
PCT/JP2009/000985 WO2009110235A1 (ja) 2008-03-05 2009-03-04 コレスタノール誘導体の併用用途

Publications (1)

Publication Number Publication Date
BRPI0908756A2 true BRPI0908756A2 (pt) 2015-07-21

Family

ID=41055800

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0908756-7A BRPI0908756A2 (pt) 2008-03-05 2009-03-04 Uso combinado de derivado do colestanol
BRPI0924525A BRPI0924525A2 (pt) 2008-03-05 2009-09-03 "derivativos de colestanol para uso combinado"

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0924525A BRPI0924525A2 (pt) 2008-03-05 2009-09-03 "derivativos de colestanol para uso combinado"

Country Status (27)

Country Link
US (6) US8088744B2 (pt)
EP (1) EP2251014B8 (pt)
JP (1) JP5336466B2 (pt)
KR (1) KR20100120674A (pt)
CN (2) CN101678037B (pt)
AR (1) AR070857A1 (pt)
AU (1) AU2009220699C1 (pt)
BR (2) BRPI0908756A2 (pt)
CA (1) CA2717135A1 (pt)
CO (2) CO6311080A2 (pt)
CY (1) CY1115217T1 (pt)
DK (1) DK2251014T3 (pt)
ES (1) ES2437640T3 (pt)
HK (1) HK1145455A1 (pt)
HR (2) HRP20140154T1 (pt)
IL (1) IL207874A (pt)
MX (1) MX2010009794A (pt)
NZ (2) NZ587729A (pt)
PL (1) PL2251014T3 (pt)
PT (1) PT2251014E (pt)
RU (1) RU2492865C2 (pt)
SG (2) SG188805A1 (pt)
SI (1) SI2251014T1 (pt)
TW (1) TWI492759B (pt)
UA (2) UA101831C2 (pt)
WO (1) WO2009110235A1 (pt)
ZA (1) ZA201006228B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2384744A1 (en) * 2004-01-14 2011-11-09 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
JP5480241B2 (ja) * 2009-03-04 2014-04-23 大塚製薬株式会社 コレスタノール誘導体の併用用途
NZ594996A (en) * 2009-03-04 2014-02-28 Otsuka Pharma Co Ltd Cholestanol derivative for combined use
WO2013179310A1 (en) * 2012-05-31 2013-12-05 Mylan Laboratories Limited Stable aqueous compositions of pemetrexed
WO2024018412A1 (en) * 2022-07-20 2024-01-25 University Of The Witwatersrand, Johannesburg 2-hydroxypropyl-beta-cyclodextrin as a cancer therapy neoadjuvant or adjuvant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5782310A (en) 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
JPS6012127A (ja) 1983-06-30 1985-01-22 Dai Ichi Seiyaku Co Ltd リポソ−ムの製法
JPS6058915A (ja) 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JPH0610131B2 (ja) 1987-10-30 1994-02-09 テルモ株式会社 リポソームの製法
JPH01167218A (ja) 1987-12-22 1989-06-30 Sumitomo Electric Ind Ltd 超電導薄膜の作製方法
JPH082780B2 (ja) 1990-05-28 1996-01-17 テルモ株式会社 リポソームの製法
JP3831958B2 (ja) 1995-09-20 2006-10-11 日本油脂株式会社 リポソーム用混合脂質及びリポソーム分散液
JP4105258B2 (ja) 1997-08-19 2008-06-25 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
JP4351314B2 (ja) 1998-12-24 2009-10-28 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
EE200200565A (et) * 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
EP1647277A4 (en) * 2003-07-17 2011-09-21 Otsuka Pharma Co Ltd LIPOSOME CONTAINING GLYCOSIDE
CA2548491A1 (en) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Synergistic anti-cancer compositions
ES2309765T3 (es) * 2004-05-28 2008-12-16 4Sc Ag Tetrahidropiridotiofenos.
TWI373473B (en) 2005-09-02 2012-10-01 Otsuka Pharma Co Ltd Anticancer agent

Also Published As

Publication number Publication date
US20150374730A1 (en) 2015-12-31
AU2009220699B2 (en) 2013-06-20
CN101969961A (zh) 2011-02-09
SG188805A1 (en) 2013-04-30
SG10201400171PA (en) 2014-06-27
CY1115217T1 (el) 2017-01-04
EP2251014A4 (en) 2012-05-23
NZ595615A (en) 2013-06-28
RU2492865C2 (ru) 2013-09-20
CO6361931A2 (es) 2012-01-20
PL2251014T3 (pl) 2014-04-30
AR070857A1 (es) 2010-05-12
US20100062053A1 (en) 2010-03-11
HRP20150418T1 (hr) 2015-05-08
ES2437640T3 (es) 2014-01-13
EP2251014A1 (en) 2010-11-17
EP2251014B8 (en) 2014-01-08
SI2251014T1 (sl) 2014-02-28
AU2009220699C1 (en) 2014-01-16
IL207874A (en) 2014-05-28
JP5336466B2 (ja) 2013-11-06
CN101678037B (zh) 2012-07-25
US20130101679A1 (en) 2013-04-25
CN101678037A (zh) 2010-03-24
KR20100120674A (ko) 2010-11-16
ZA201006228B (en) 2011-11-30
CO6311080A2 (es) 2011-08-22
NZ587729A (en) 2012-03-30
US20120015025A1 (en) 2012-01-19
PT2251014E (pt) 2014-02-14
EP2251014B1 (en) 2013-11-20
HRP20140154T1 (hr) 2014-03-14
JPWO2009110235A1 (ja) 2011-07-14
TW200940097A (en) 2009-10-01
US20140178464A1 (en) 2014-06-26
MX2010009794A (es) 2010-12-21
US8088744B2 (en) 2012-01-03
HK1145455A1 (en) 2011-04-21
CN101969961B (zh) 2013-01-16
TWI492759B (zh) 2015-07-21
US20120009251A1 (en) 2012-01-12
WO2009110235A1 (ja) 2009-09-11
BRPI0924525A2 (pt) 2016-03-01
IL207874A0 (en) 2010-12-30
UA101831C2 (uk) 2013-05-13
CA2717135A1 (en) 2009-09-11
UA101884C2 (uk) 2013-05-13
DK2251014T3 (da) 2013-12-02
AU2009220699A1 (en) 2009-09-11
RU2010140611A (ru) 2012-04-10

Similar Documents

Publication Publication Date Title
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0821668A2 (pt) Uso
BRPI0906186A2 (pt) composto e uso de um composto
DK2273984T3 (da) Lipidsammensætning
BRPI0911563A2 (pt) uso de antagonista da progesterona
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
DK2308877T3 (da) Imidazopyridin-2-on-derivater
DOP2010000260A (es) Derivado heterociclico fusionado y su uso
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI0913833A2 (pt) uso de corantes ácidos
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
DK2125048T3 (da) Præparat
DK2275414T3 (da) Cyclopentylacrylamidderivat
ITMI20080003A1 (it) Composizioni per uso oftalmico
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI1011036A2 (pt) uso
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0923550A2 (pt) penico
BRPI0909223A2 (pt) uso de catepsaina c
BRPI0909840A2 (pt) Uso de 4-tio-2-deoxinucleosídios
BRPI0908756A2 (pt) Uso combinado de derivado do colestanol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]